Experimental drug for pyoderma gangrenosum ulcers
Part of Skin clinical trials.
This study tests an experimental drug called SHR-1139 to see if it can help heal skin ulcers caused by pyoderma gangrenosum. If you qualify, you would receive the study drug and be monitored for safety and effectiveness.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have been diagnosed with ulcerative pyoderma gangrenosum.
- You have at least one skin ulcer that is at least 5 cm² (about the size of a small egg).
- You have no other conditions that cause similar skin ulcers.
- You are not pregnant or breastfeeding, and you agree to use birth control during the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an investigational drug called SHR-1139 for adult patients with ulcerative pyoderma gangrenosum (a type of painful skin ulcer). The goal is to see if the drug is safe and helps heal the ulcers.
This trial tests whether the drug spesolimab can help people with a skin condition called pyoderma gangrenosum, which causes painful ulcers. It's for adults who have at least one active ulcer that's at least 2 inches across and needs treatment.
This study tests a cream called ruxolitinib to treat pyoderma gangrenosum, a painful skin condition that causes deep ulcers. The cream is applied directly to the ulcer and may help it heal without the side effects of pills or injections.
This study tests a medication called bimekizumab to see if it helps people with pyoderma gangrenosum, a painful skin condition that causes deep ulcers. If you qualify, you'll receive the treatment and be monitored for about a year.
This study tests an investigational drug called SHR-1139 for people with moderate-to-severe plaque psoriasis who have not responded well to previous biologic treatments. The goal is to see if it can reduce psoriasis symptoms safely.
This study tests a new injection called SHR-1139 for people with moderate-to-severe plaque psoriasis. The goal is to see if it can safely improve your skin condition.
Hear when a new Pyoderma Gangrenosum trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.